Compound class:
Endogenous peptide in human, mouse or rat
Comment: Homodimeric endogenous peptide ligand consisting of two subunits chains of inhibin βA. Interacts with activin type I and II receptors.
Species: Human
|
References |
1. Sun J, Tam L-TT, Han H-Q, Kwak KS-N, Zhou X, Lu J. (2013)
Variant activin receptor polypeptides and uses thereof. Patent number: US8501678 B2. Assignee: Atara Biotherapeutics, Inc.. Priority date: 06/03/2007. Publication date: 06/08/2013. |
2. Suragani RN, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, Davies MV, Alexander MJ, Devine M, Loveday KS et al.. (2014)
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med, 20 (4): 408-14. [PMID:24658078] |